Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days

Not Applicable

Completed

• Conditions: Dry Eye

• Registration Number: NCT00946777
• Lead Sponsor: Alcon Research

Brief Summary

The primary objective is to determine if there is a correlation between reductions in corneal staining and improvements in corneal barrier function.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-07
• Study First Submitted: 2009-07-24
• Study First Submitted QC: 2009-07-24
• Study First Posted: 2009-07-27
• Primary Completion: 2009-09
• Study Completion: 2009-09
• Status Verified: 2012-02
• Last Update Submitted: 2016-11-17
• Last Update Posted: 2016-11-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

• Patients must have moderate corneal staining and exhibit a need to use artificial tears.

Exclusion Criteria

• Patients can not participate in any other ophthalmic drug or device clinical trial within 30 days of the baseline visit.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Percent change from baseline of corneal fluorescein	30 days

Secondary Outcome Measures

Name	Time	Method
Adverse event occurence	30 Days